Export boom masks volume stall and margin compression
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Management met FY26 margin targets (25%+) in prior years. Q1 FY27 miss (21.9% vs 25–30%) attributed to one-time freight surge (₹9 Cr) and Gulf War impact. Restated 10–12% growth, 25%+ margins as sustainable long-term but hedged heavily on near-term, blamed macro volatility.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong export OEM momentum (+40% YoY) and 38% PAT growth are real, but delivered on weak 2% organic volume growth and 21.9% OPM — below prior 25–30% guidance. Management has not recovered pricing power (no hikes in highest-margin export OEM segment despite 4x freight/RM inflation) and domestic auto is flat despite 18–20% industry tailwinds, signaling market-share loss risk. Near-term margin recovery hinges on freight/RM normalization and customer pricing acceptance—neither certain.
₹269.2 Cr
Revenue · +24.7% YoY₹56.1 Cr
Reported PAT · +37.8% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
25% growth driven by volume and pricing mix
MISSVolume only 2% (export 9%, domestic 1%); 23% from price/mix realization
Export OEM business has strong momentum expected 2–3 years
METExport OEM +40% YoY to ₹74 Cr; US customers wallet-share dependent, no price increases taken despite 4x freight costs
Sustainable margins 25–27% in this quarter going forward
OVERSTATEDQ1 OPM 21.9%, below prior 25–30% guidance. Management blamed one-time freight (₹9 Cr expense jump), RM volatility, no price hikes
Domestic market performing well, footwear segment growing
MISSDomestic volume +1% only; footwear segment degrowth due to sole/PVC price spike; auto OEM flat despite 18–20% industry growth
Capacity utilisation headroom, not a constraint for growth
MET75–78% utilisation on 3.5M meters capacity. Tight, not loose. New +5 lakh line adds 4M–4.2M capacity by Mar 2027, bringing utilisation to ~65–66%
Earnings quality
What changed since the last call
Volume growth guidance cut
DowngradePrior FY26 calls: 15–20% international growth expected. Q1 FY27 delivery: 9% export volume growth, 1% domestic. Mgmt now guides 10–12% overall 3-year CAGR (below prior range). Organic demand weak.
Margin sustainability redefined
DowngradePrior target: 25–30% margins. Q1 delivered: 21.9% OPM. Mgmt now claims '25 plus 1–2%' sustainable (25–27%), not 25–30%. One-time cost headwinds (freight, RM) cited; recovery timeline unclear.
Domestic auto outlook dimmed
DowngradePrior calls implied domestic auto growth with broader automotive OEM ramps. Q1: domestic volume +1% despite 18–20% industry growth. Mgmt now focuses on 'very strong export growth,' not domestic. Market-share loss risk acknowledged.
Export OEM pricing power lost
DowngradePrior calls did not flag pricing constraints. Q1: export OEM +40% revenue but NO price increases taken despite 4x freight costs and RM inflation. Mgmt sent price-hike mails but market softened; chose not to push. Pricing power weak.
Global capex delayed
WithdrawnPrior guidance: ₹300 Cr global location + ₹50 Cr India expansion. Q1: India ₹50 Cr proceeding (Feb–Mar 2027 capacity online). Global ₹250 Cr still 'evaluating location' (Mexico/US/NAFTA); no final call. Execution risk, timeline extended.
The Q&A
Analysts pressed hard on margin compression, domestic auto flat, export OEM pricing constraints, and global capex delays. Management defended margins as 'sustainable 25%+' despite near-term headwinds, blamed macro volatility (Gulf War, RM spikes), and deflected on near-term price-hike timing. Tone defensive, hedged on when pricing power returns. CFO had health issue (slight infection); filled gaps. Analysts accepted long-term framing but skepticism evident.
Volume vs pricing growth — Shubham Jain, NV Alpha Fund
AnsweredVolume ~2%, rest from pricing/mix (export business higher-priced items, product mix upgrade)
Capex and expansion plans — Shubham Jain, NV Alpha Fund
Partial₹50 Cr FY27 (Feb–Mar 2027 production start, +5 lakh meters). Two more expansions evaluating (one outside India, one India). Outside India location (Mexico/US/NAFTA) still being decided due to volatility.
Export segment breakdown — Saloni, Molecule Ventures
AnsweredExport ₹103.80 Cr, domestic ₹143.23 Cr
Margin sustainability — Saloni, Molecule Ventures
AnsweredQ4 abnormally high due to forex; Q1 is sustainable (25+ 1–2%). Market volatile. This margin expected to continue.
Volume breakdown — Viraj Kacharia, SiMPL
AnsweredExport volume +9%, domestic +1% (footwear degrowth due to sole/PVC spike). Flat auto, but not all segments. Replacement/footwear weak.
Export margin and pricing — Viraj Kacharia, SiMPL
PartialRM inflation started March, market volatile. Strategic reasons prevent price pushes for all customers. 10% natural hedge from USD appreciated but RM exceeded that. Very volatile situation out of control.
Export OEM pricing pressure — Kiran, TableTree
AnsweredGulf War impacted price in Q1; shipping costs 4x higher. Requested price increases but market softened mid-quarter. 10% natural hedge from USD. No price increase from customer yet.
Other expense increase — Kiran, TableTree
AnsweredMostly shipping (4x due to Gulf War), plus travel, professional fees. Will decline if war situation improves.
FTA impact — Aman Soni, Seven Alpha Investors
PartialPositive move. More cost-effective. Europe customer sentiments good; de-risking policies may ease. Cannot quantify business uplift yet.
Competitive landscape — Aman Soni, Seven Alpha Investors
AnsweredBusiness driven by OEM, not tier-1. Uno Minda in two-wheeler seats, we are supplier. Four-wheeler growth from Mahindra (increasing) and Tata (early stage). Depends on platform awards.
US OEM growth outlook — Raman KV, Sequent Investments
Partial60–70% growth over 3 years expected (via wallet-share expansion with existing customers like Ford, Chrysler). New OEMs in early stage, cannot comment. Will be extra if wins.
Price hike timing — Raman KV, Sequent Investments
PartialSent price-hike mails to US OEM but market softened, did not push. Already got 10% USD appreciation benefit. Will watch market stabilization before pushing further.
Capex recurring expense — Ashwini Damini, Ratnabali
DodgedBreakup unclear, needs analysis. Partly recurring (some subsidiary), partly will decline. Cannot give exact figures.
Capex FY27–28 — Ravi Naredi, Naredi Investment
AnsweredFY27: ₹50 Cr. FY28: Depends on final call on new facility. If approved, ₹250 Cr additional over 2 years.
RM pricing and margin — Madhur Rathi, Counter Cyclical Investments
PartialSome RM softer, some up again (volatile). Still more expensive than Feb-end. Gross margin improvement possible QoQ but no guarantee.
Global plant rationale — Shreyans Gandhi, SG Securities
AnsweredMarket uncertain, OEMs want nearby suppliers to de-risk. If we don't have local plant, growth limited long-term. Global presence improves brand image with customers.
Margin base — Awanish Chandra, SMIFS
AnsweredTake current margin for granted. What's extra, consider bonus. Always strive for best. Year-end margin matters due to QoQ ups/downs.
PU plant strategy — Saloni, Molecule Ventures
AnsweredUnderutilized, loss-making. RM prices volatile (PU and sole costs spike). Talking to top brands, sampling done, no confirmed orders. Export market tough vs China. No strong recommendation for PU this FY.
Guidance
10–12% revenue CAGR over next 3 years
MediumStated as 'already communicated.' Management caveated with '10–15% due to uncontrollable factors.' Domestic auto weak; export strong. Blended guidance conservative.
25–27% OPM sustainable long-term
MediumPrior guidance 25–30%. Q1 delivered 21.9% (one-time freight, RM factors). Management reiterated 25%+ as achievable, depends on RM/freight normalization and pricing power recovery (uncertain).
FY27: ₹50 Cr (new line, current facility)
HighLine already ordered; production start Feb–Mar 2027; +5 lakh meters capacity (14% increase).
FY28+: ₹250 Cr if global expansion approved
LowLocation still evaluating (Mexico/US/NAFTA options). No final call; timeline uncertain. Strategic but execution risk high.
Risks the call surfaced
Margin pressure from input costs
HighRM prices volatile (March spike), shipping costs 4x elevated (Gulf War). Management sent price-hike mails to US OEM but market softened; chose not to push. 21.9% OPM below 25–30% guidance. Recovery depends on cost normalization + customer acceptance (uncertain).
Domestic auto market-share loss
MediumDomestic auto OEM volume +1% despite 18–20% industry growth (auto production data cited by analyst). Implies losing market share or selective growth. Tata/Mahindra ramps slow. Footwear segment explicit degrowth (sole prices 2–3x spike). Domestic 58% of revenue; stall here is material headwind.
Export OEM customer concentration & order book opacity
MediumExport OEM ₹73.56 Cr (30% of total, +40% YoY) concentrated in Ford/Chrysler wallet-share expansion. No order book detail given; analyst asked, mgmt deferred. Growth is wallet-share, not new customer wins (so far). Dependency on 2–3 customers for 30% of revenue creates risk.
Global capex execution delay
MediumPrior guidance: ₹300 Cr global + ₹50 Cr India. Q1 status: India ₹50 Cr on track (Feb–Mar 2027). Global ₹250 Cr still 'evaluating location' (Mexico/US/NAFTA). Macro volatility (Trump tariffs, West Asia war) cited as inhibitor. No final call; timeline extended. Risk: competitive delay while location is decided; execution slip beyond FY27.
Freight cost & logistics vulnerability
MediumShipping costs 4x elevated due to Gulf War (cited for Q1). ₹9 Cr quarterly expense jump attributed to freight. Management uncertain on persistence ('depends on war situation'). If shipping rates remain elevated 6+ months, it becomes structural cost drag, not one-time.
Management
Score 6/10. Clear on numbers and segment breakdown; but hedged on near-term actions (price hike timing, global capex location). Defensive tone on margins, deflected to long-term framing. CFO had health issue (slight infection), filling gaps. Met FY26 margin targets historically. Q1 FY27 margin miss (21.9% vs 25–30%) attributed to one-time freight/RM surge, not operational failure. India capex (₹50 Cr, new line) on track for Feb–Mar 2027. Global capex still evaluating location; execution risk, timeline extended.
1 · Feb–Mar 2027
+5 lakh meter line production start; capacity +14% to 4M–4.2M meters/month
2 · Next 2–3 quarters
Freight/shipping cost normalization post-Gulf War; RM price stabilisation; management will pursue export OEM price increases
3 · End 2026
Global expansion location decision; if approved, ₹250 Cr capex over 2 years (Mexico/US/NAFTA options)
Near-term margin recovery hinges on freight/RM normalization and customer pricing acceptance—neither certain.
Informational and educational content only. Not investment advice.